Open Science Drug Discovery Model Expands to Neurodegeneration
Following in the path of M4K Pharma, a new initiative called M4ND Pharma (Medicines for Neurodegeneration) will tackle neurodegenerative diseases such as Parkinson’s disease, thanks to funding from the Krembil Foundation, and will commit to open science practises, open sharing of data, and affordable pricing.